bioAffinity Technologies BIAF Q3 2025 Earnings Significant EPS Miss as Revenue Remains Zero Stock Declines 37 REYN Q1 2026 Earnings EPS Surpasses Estimates by 136 Revenue Not Disclosed QURE Q1 2026 Earnings Narrowed Loss Beats Estimates as Gene Therapy Pipeline Steadies APWC Q3 1997 Earnings Missed Estimates Amid Operational Challenges BBU Q4 2025 Earnings Significant Earnings Miss Impacts Quarterly Results BIP Q1 2026 Earnings Significant EPS Miss Amidst Operational Headwinds